TABLE 2.
Correlation between SMARCC1 expression and pathological characteristics of PCa.
| Pathological characteristics | Immunohistochemical staining intensity |
χ2 | P-value | ||
| Low (n, %) | Medium (n, %) | Strong (n, %) | |||
| Age | |||||
| ≤60 | 4 (100) | – | – | 2.664 | 0.264 |
| >60 | 57 (59.4) | 31 (32.3) | 8 (8.3) | ||
| Gleason score | |||||
| ≤7 | 27 (50) | 23 (42.6) | 4 (7.4) | 7.469 | 0.024 |
| >7 | 34 (73.9) | 8 (17.4) | 4 (8.7) | ||
| T stage | |||||
| T1–2 | 7 (46.7) | 6 (40) | 2 (13.3) | 1.547 | 0.461 |
| T3–4 | 50 (63.3) | 23 (29.1) | 6 (7.6) | ||
| Metastasis to lymph nodes | |||||
| Yes | 17 (73.9) | 6 (26.1) | – | 3.439 | 0.179 |
| No | 44 (57.1) | 25 (32.5) | 8 (10.4) | ||
| Invasion to seminal vesicle | |||||
| Yes | 37 (58.7) | 21 (33.4) | 5 (7.9) | 0.375 | 0.829 |
| No | 21 (63.6) | 9 (27.3) | 3 (9.1) | ||
| AJCC clinicopathological stage | |||||
| I–IIc | 6 (50) | 4 (33.3) | 2 (16.7) | 3.348 | 0.501 |
| IIIa–IIIc | 49 (60.5) | 26 (32.1) | 6 (7.4) | ||
| IVa–IVb | 6 (85.7) | 1 (14.3) | 0 | ||
| ERG staining | |||||
| Negative | 37 (63.8) | 15 (25.9) | 6 (10.3) | 3.477 | 0.176 |
| Positive | 9 (42.9) | 10 (47.6) | 2 (9.5) | ||
Bold values illustrate statistical significance.